Betulin	O
induces	O
mitochondrial	B-Cellular_component
cytochrome	O
c	O
release	O
associated	O
apoptosis	O
in	O
human	O
cancer	B-Cell
cells	I-Cell
.	O

We	O
examined	O
whether	O
betulin	O
,	O
a	O
naturally	O
abundant	O
compound	O
,	O
has	O
anticancer	B-Cancer
functions	O
in	O
human	O
cancer	B-Cell
cells	I-Cell
.	O

The	O
results	O
showed	O
that	O
betulin	O
significantly	O
inhibited	O
cell	B-Cell
viability	O
in	O
cervix	B-Cell
carcinoma	I-Cell
HeLa	I-Cell
cells	I-Cell
,	O
hepatoma	B-Cell
HepG2	I-Cell
cells	I-Cell
,	O
lung	B-Cell
adenocarcinoma	I-Cell
A549	I-Cell
cells	I-Cell
,	O
and	O
breast	B-Cell
cancer	I-Cell
MCF	I-Cell
-	I-Cell
7	I-Cell
cells	I-Cell
with	O
IC	O
(	O
50	O
)	O
values	O
ranging	O
from	O
10	O
to	O
15	O
microg	O
/	O
mL	O
.	O

While	O
betulin	O
exhibited	O
only	O
moderate	O
anticancer	B-Cancer
activity	O
in	O
other	O
human	O
cancer	B-Cell
cells	I-Cell
such	O
as	O
hepatoma	B-Cell
SK	I-Cell
-	I-Cell
HEP	I-Cell
-	I-Cell
1	I-Cell
cells	I-Cell
,	O
prostate	B-Cell
carcinoma	I-Cell
PC	I-Cell
-	I-Cell
3	I-Cell
,	O
and	O
lung	B-Cell
carcinoma	I-Cell
NCI	I-Cell
-	I-Cell
H460	I-Cell
,	O
with	O
IC	O
(	O
50	O
)	O
values	O
ranging	O
from	O
20	O
to	O
60	O
microg	O
/	O
mL	O
,	O
it	O
showed	O
minor	O
growth	O
inhibition	O
in	O
human	O
erythroleukemia	B-Cell
K562	I-Cell
cells	I-Cell
(	O
IC	O
(	O
50	O
)	O
>	O
100	O
microg	O
/	O
mL	O
)	O
.	O

We	O
further	O
investigated	O
the	O
mechanism	O
of	O
anticancer	B-Cancer
activity	O
by	O
betulin	O
,	O
using	O
HeLa	B-Cell
cells	I-Cell
as	O
an	O
experimental	O
model	O
.	O

Betulin	O
(	O
10	O
microg	O
/	O
mL	O
)	O
induces	O
apoptotic	O
cell	B-Cell
death	O
,	O
as	O
evidenced	O
by	O
morphological	O
characteristics	O
such	O
as	O
membrane	B-Cellular_component
phosphatidylserine	O
translocation	O
,	O
nuclear	B-Cellular_component
condensation	O
/	O
fragmentation	O
,	O
and	O
apoptotic	B-Cellular_component
body	I-Cellular_component
formation	O
.	O

A	O
kinetics	O
analysis	O
showed	O
that	O
the	O
depolarization	O
of	O
mitochondrial	B-Cellular_component
membrane	I-Cellular_component
potential	O
and	O
the	O
release	O
of	O
mitochondrial	B-Cellular_component
cytochrome	O
c	O
occurred	O
as	O
early	O
as	O
30	O
min	O
after	O
treatment	O
with	O
betulin	O
.	O

Betulin	O
,	O
unlike	O
its	O
chemical	O
derivative	O
betulinic	O
acid	O
,	O
did	O
not	O
directly	O
trigger	O
mitochondrial	B-Cellular_component
cytochrome	O
c	O
release	O
in	O
isolated	O
mitochondria	B-Cellular_component
.	O

Importantly	O
,	O
Bax	O
and	O
Bak	O
were	O
rapidly	O
translocated	O
to	O
the	O
mitochondria	B-Cellular_component
30	O
min	O
after	O
betulin	O
treatment	O
.	O

The	O
sequential	O
activation	O
of	O
caspase	O
-	O
9	O
and	O
caspase	O
-	O
3	O
/	O
-	O
7	O
and	O
the	O
cleavage	O
of	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
(	O
PARP	O
)	O
were	O
observed	O
behind	O
those	O
mitochondrial	B-Cellular_component
events	O
.	O

Furthermore	O
,	O
specific	O
downregulation	O
of	O
either	O
caspase	O
-	O
9	O
,	O
Bax	O
,	O
or	O
Bak	O
by	O
siRNA	O
effectively	O
reduced	O
PARP	O
cleavage	O
and	O
caspase	O
-	O
3	O
activation	O
.	O

Taken	O
together	O
,	O
the	O
lines	O
of	O
evidence	O
demonstrate	O
that	O
betulin	O
triggers	O
apoptosis	O
of	O
human	O
cancer	B-Cell
cells	I-Cell
through	O
the	O
intrinsic	O
apoptotic	O
pathway	O
.	O

